Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis.

Chengrun DuMengshan NiJianyun JiangFangfang KongRuiping ZhaiYingchen LvChaosu HuChengrun Du

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)

Taxane/gemcitabine-containing chemotherapy combined with IMRT represents an effective treatment modality for mNPC. Baseline ALC is an independent significant prognostic factor for PFS and OS.

Keyphrases

prognostic factors
locally advanced
squamous cell carcinoma
rectal cancer
radiation therapy
small cell lung cancer
metastatic breast cancer
chemotherapy induced
replacement therapy